Align Technology forecast its first-quarter revenue below analysts' estimates on Wednesday, signaling soft demand for its clear teeth aligners from teenagers and younger patients.
Here is a sneak peek into how five MedTech stocks, BSX, HOLX, TECH, STE and ALGN, are expected to fare in their quarterly results, slated to be released tomorrow.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Align Technology (ALGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
Focus on companies with proven business models, strong management, and potential for long-term market share growth in large industries. M&T Bank, Ashtead Group, Installed Building Products, Fiserv, Ferguson, Kinsale Capital Group, Align Technologies, and Medpace Holdings are highlighted investments. Emphasis on conservative financial practices, market dominance, and strategic capital deployment to drive future growth and shareholder value.
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Labcorp (LH) or Align Technology (ALGN). But which of these two companies is the best option for those looking for undervalued stocks?
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology's fourth-quarter results are likely to reflect the strength in its Systems & Services business.
Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This resulted in a decline in the company's revenues.
Two stocks (ALGN and KO) to buy in January trading at least 20% below their average Zacks price targets that also offer great long-term value.
Leerink Partners upgraded Align Technology Inc ALGN, citing upside opportunities throughout 2025 given gross margin expansion opportunities.